Holstein Dairy Heifers Research Articles

Endocrine responses and ovarian changes in inseminated dairy heifers after an injection of a GnRH agonist 11 to 13 days after estrus1

Our objective in this study was to determine endocrine responses and changes in ovarian structures after a single injection of a GnRH agonist in Holstein dairy heifers (n = 38). Heifers were inseminated and received (i.m.) either saline or 200 micrograms of fertirelin acetate once on d 11, 12, or 13 after estrus (d 0). Blood was collected at 15- to 30-min intervals for 6 h after the injection to determine concentrations of LH, FSH, estradiol (E), and progesterone (P) in serum and once daily for 8 to 12 d after the injection to determine concentrations of E and P. Pregnancy rates were 58% (11 of 19) in both treatment groups. Diameter of the corpus luteum and numbers and appearance of ovarian follicles were determined by real-time ultrasonography on d-1 through 5 after injection. No treatment-induced ovulations or changes in the number of ovarian follicles were observed after the injection of the GnRH agonist. More (P less than .05) of the largest follicles within heifers receiving fertirelin acetate showed changes in their appearance on at least the 1st d after injection (6 of 10 vs 1 of 9 control heifers). Fertirelin acetate induced release of LH and FSH from the pituitary within 15 min of injection; both hormones reached peak concentrations at 120 min and then returned to pretreatment concentrations by 300 to 360 min after injection.(ABSTRACT TRUNCATED AT 250 WORDS)

Effect of relaxin on facilitation of parturition in dairy heifers

Purified pig relaxin (3000 U/mg) was injected i.m. into pregnant Holstein dairy heifers on Day 276 or 277 to determine its effect on parturition and sequential measurements of the pelvic area, cervical dilatation, and peripheral blood-plasma concentrations of progesterone and relaxin. Treatments included phosphate-buffer saline (2 ml, Group C, N = 7), relaxin once (1 mg, Group 1R, N = 7), and twice (2 mg, 12 h apart; Group 2R, N = 7). Intervals (mean +/- s.e.) between the first injection of relaxin or PBS and calving were 64 +/- 17, 80 +/- 19 and 125 +/- 34 h for Groups 2R, 1R and C, respectively. The calving intervals were reduced in Groups 2R (P less than 0.01) and 1R (P less than 0.05) compared with Group C. The incidence of dystocia was 29% (2 of 7) in Group 2R and 43% (3 of 7) in Group 1R compared with 57% (4 of 7) in Group C (P less than 0.01). Body weights and ratios of males to females of the calves were similar (P greater than 0.05) between groups. Progesterone plasma concentrations decreased (P less than 0.01) earlier in Groups 1R and 2R compared with Group C, and this acute decrease began within 6 h of treatment. At 24 h after relaxin or PBS injection, progesterone concentrations were 2.7 +/- 1.1 ng/ml for Group 2R, 3.5 +/- 0.9 ng/ml for Group 1R, and 6.0 +/- 0.1 ng/ml for Group C. Relaxin reached peak blood-plasma levels of 19 +/- 2.2 ng/ml 1 h after injection of relaxin, but remained unchanged, 0.3 +/- 0.01 ng/ml, in Group C. Pelvic area was increased 26%, 22% and 14% and cervical dilatation was increased 109%, 76% and 53% 48 h after injection in Groups 2R, 1R and C, respectively, but these responses were similar among groups at the time of parturition. We conclude that two i.m. injections of relaxin facilitated earlier calving, acutely decreased progesterone secretion, increased cervical dilatation and pelvic area expansion, and decreased the incidence of dystocia in dairy heifers.

Standards of Weight and Height for Holstein Heifers

To develop a modern appraisal of growth of Holstein dairy heifers, height at withers and heart girth (body weight) data were collected for 5723 heifers representing 163 commercial Holstein dairy herds from October 1983 through May 1985. Quadratic regression equations of height and weight on age were computed for each herd. Estimated weight and height of heifers at 24 mo from these equations were found to be correlated with herd variables such as herd average milk production and age at first calving. Means and standard deviations for height and weight were determined for each age (1 through 24 mo). Third order regressions on age were fitted to the means to describe height and weight. Estimated height (cm) and weight (kg) at 6, 12, 18, and 24 mo were 101.0, 167.2; 117.6, 299.1; 127.4, 420.6; and 132.7, 516.2. A subset of data containing heifers in 89 herds that had a herd average milk production of >7264kg were also fitted to third order regression on age. Weight and height of dairy heifers are moderately larger in herds with >7264kg average milk production. Based on the entire data set, commercial Holstein herds in Pennsylvania have heifers somewhat larger than those used to develop National Research Council recommendations.

Postpartum uterine motility measurements in dairy cows retaining their fetal membranes

Postpartum uterine contraction variables were measured in 15 parturient Holstein dairy cows and heifers: 8 assigned to dexamethasone (DEX) treatment and 7 to control (CON) treatment. The DEX animals were induced to calve early with an injection of dexamethasone and estradiol benzoate, administered on days 270 to 274 of gestation. At this time, the CON animals were injected with sterile saline and allowed to calve at term. Six of the eight DEX animals and one of the seven CON animals retained their fetal membranes longer than 12 hours postpartum. The uterine contraction variables determined were: the number of contractions over a 10 minute period ( C 10 ), the average amplitude of contractions (AMP), the average duration of contractions (DUR), Montevideo units (MONT) and Alexandria units (ALEX). Recordings were taken at 1 hour, 6 hours and 48 hours postpartum, for a period of 20 minutes each. The contraction variables were measured using a catheter which was fluid-filled and inserted into the pregnant horn and connected to a pressure transducer, amplifier and recorder. The data were analyzed in terms of DEX vs. CON animals and animals with retained fetal membranes (RET) vs. animals with a normal release (NRET). Treatment with dexamethasone and estradiol benzoate resulted in an increase in C 10 at 48 hours (P < .05). The AMP, MONT and ALEX variables were also higher in the DEX animals, as compared to controls at that time. Significant differences (P < .01) were observed at 48 hours postpartum between the RET and NRET animals in terms of AMP, MONT and ALEX variables, and at that time the RET animals had a higher rate of uterine contractility than the NRET animals. No significant differences in the amount of uterine work between either the DEX and CON animals or the RET and NRET animals were observed, at 1 and 6 hours postpartum. The treatment with dexamethasone and estradiol benzoate prolonged uterine motility up to 48 hours postpartum, and the retention of the fetal membranes was not a result of the lack of uterine contractility during the early stages postpartum.

Effect of melengestrol acetate on the bovine ovary.

To investigate the relation of ovarian morphology to increased body weight gain during administration of melengestrol acetate (17-acetoxy-6-methyl-16-methylenepregna-4,6-diene-3,20-dione, or MGA, a progestagen), ovaries of 100 Holstein dairy heifers were examined for characteristics of follicular maturation, signs of lipid secretion, and the presence of steroid-producing-type cell organelles. The heifers were fed either a normal or a high-protein level ration with or without 0.30–0.45 mg daily of MGA from 2.5 months of age to the age of first estrus or to breeding age (120 cm withers height). The high-level ration effect was not consistently mediated by the special development of ovarian structures. MGA effect, like the weight-gain effect, was consistently evident after the time of first estrus. MGA suppressed estrus and ovulation, and resulted in the presence in the ovary, after regression of corpora lutea, of an increased number of large follicles. The largest follicles corresponding in structure to developing proestrous, mature estrous, or early atretic follicles contained hypertrophied theca interna cells showing lipid secretion signs and ultrastructural characteristics of steroid synthesis. The majority of the largest follicles, however, were atretic or late atretic and did not contain steroid-type cells. The development of replacement follicles was evident in ovaries with late atretic largest follicles. The weight-gain effect of MGA may therefore be associated with a steroidogenic, probably estrogenic, effect in the cow.

High-Level Urea Feeding to Dairy Cattle. I. Effect of High-Level Urea Feeding on the Growth and Metabolism of Growing Dairy Heifers without Sulfur Supplementation

Summary Twenty-four Holstein dairy heifers wera used in a 150-day trial to study the effect of feeding grain rations containing 3.0, .5.0, and 7.0% urea upon growth, feed consumption, and metabolism. Ground corn cobs were fed as the sole source of roughage. As the levels of urea in the ration increased, the consumption of corn cobs decreased, although not significantly, and daily gains and feed efficiency decreased significantly. The average daily gain for heifers fed rations containing 3.0, 5.0, and 7.0% urea were 1.14, 0.85, and 0.64lb. per day, respectively. The level of urea in the ration did not significantly affect nitrogen retention or blood levels of urea nitrogen, but as the intake of urea increased, blood serum levels of nonprotein nitrogen increased significantly and the levels of serum proteins significantly decreased. The possibility of a sulfur deficiency in a ration containing either 5.0 or 7.0% urea was discussed.